NEWS
Special Reports
All News
FDA Briefs
Oncology Icons
The Targeted Pulse
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Evolving Paradigms in Oncology
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Practice Playbook
Shorts
Video Series
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Events
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Scout
My Account
Scout
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
BRAIN CANCER
BREAST CANCER
HER2 Breast Cancer
COMMUNITY ONCOLOGY PRACTICE
GENITOURINARY CANCERS
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
GENOMIC TESTING
Liquid Biopsies
GI CANCERS
Pancreatic Cancer
Colorectal Cancer
Gastric Cancer
GIST
HCC
GYNECOLOGIC CANCERS
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
HEAD & NECK CANCERS
HEMATOLOGY
Bone Marrow & Stem Cell Transplant
IMMUNOTHERAPY
CAR T-Cell Therapy
LEUKEMIAS
AML
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
LUNG CANCER
MET-Targeted Therapy
Small Cell Lung Cancer
Biomarker-Driven Lung Cancer
EGFR+ Lung Cancer
LYMPHOMAS
DLBCL
Follicular Lymphoma
Mantle Cell Lymphoma
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
ONCOLOGY POLICY
SARCOMA
SKIN CANCERS
Melanoma
THYROID CANCERS
Choose Specialty
Spotlight -
Community Oncology Practice
|
Oncology Policy
|
Myeloma
|
CLL
|
Genomic Testing
|
GU Cancers
Advertisement
Heavily Pretreated Recurrent Ovarian Cancer
EP. 1: Recurrent Advanced Ovarian Cancer: Case Impressions
July 30th 2019
EP. 2: Managing Recurrent Advanced Ovarian Cancer in the Current Era
July 30th 2019
EP. 3: Treatment Sequencing in Advanced Ovarian Cancer
July 30th 2019
EP. 4: Improving the Management of Advanced Ovarian Cancer
July 30th 2019
EP. 5: Advanced Ovarian Cancer After Third-Line Therapy
July 30th 2019
EP. 6: PARP Inhibitors in Advanced Ovarian Cancer
July 30th 2019
EP. 7: Managing Patients Treated With PARP Inhibitors
July 30th 2019
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
2
2026 ASCO Plenary Delivers Practice-Changing Progress
3
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
4
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
5
May 2026: FDA Oncology Actions at a Glance
